Mitolyn Reviews – Effective Health...
Insurance1 min ago
Coronavirus Vaccine
13 Answers
Hi there
I keep hearing a vaccine for covid could be widely available by next year, however am I right in saying the virus is very similar to the common cold virus, I can't get my head around how a vaccine for a virus they know very little about can be rolled out so quickly
There has never been a vaccine for the common cold so how can one for covid be created so quickly
I keep hearing a vaccine for covid could be widely available by next year, however am I right in saying the virus is very similar to the common cold virus, I can't get my head around how a vaccine for a virus they know very little about can be rolled out so quickly
There has never been a vaccine for the common cold so how can one for covid be created so quickly
Answers
1 to 13 of 13
Best Answer
No best answer has yet been selected by breadstick. Once a best answer has been selected, it will be shown here.
For more on marking an answer as the "Best Answer", please visit our FAQ.
Coronaviruses have been extremely difficult to develop any vaccine so far.
Flu may have similarities but it also has differences.
https:/
Flu may have similarities but it also has differences.
https:/
I can't explain why Covid specifically is comparatively easy to make a vaccine for, at least compared to a cold. Party of it, presumably, is the incentive to make one: a disease that has the potential to kill so many is far more of a threat than a disease that has the potential to make people miserable for a few days, and has prompted one of the most intense medical research programmes in history.
Also, there is no single "cold" virus, but a couple of hundred of them: you'd have to make a vaccine for each one, or a vaccine in combination. Also, the mutation rate is faster than a vaccine can keep up with.
This presumably also explains why flu vaccine is both important and also annual: the virus also mutates, so no one vaccine would be useful for long, but since flu actually *does* have the potential to kill, it's that much more important to have a vaccine for it.
Also, there is no single "cold" virus, but a couple of hundred of them: you'd have to make a vaccine for each one, or a vaccine in combination. Also, the mutation rate is faster than a vaccine can keep up with.
This presumably also explains why flu vaccine is both important and also annual: the virus also mutates, so no one vaccine would be useful for long, but since flu actually *does* have the potential to kill, it's that much more important to have a vaccine for it.
// Lol.....what a very good point.
Peter P will be along shortly to explain.(if you can understand him.)//
see one oclock news today - really very good summing up
but I did stir them up with the observation that antibody levels werent be all and end all.
but
There has never been a vaccine for the common cold so how can one for covid be created so quickly
easy - common cold 200 types and easily mutates
covid so far - - - mutation but very little
and some covid bits - no mutation so it makes sense to get an antibody against the non changing bits
that OK isnt it?
Incomprehensible bit - the virus docks on a well described human cell receptor and then gains entry to the cell and KKKKKIIIIIILLLLS it and so
define the protein bit of that part - - - and get a vaccine
because the antibody should - - - interfere with docking
actually they have identified a very stable sequence ( the idea is if the sequence changes then the virus wont dock) just under the binding site and one of the vaccines is against that sequence
the one oclock summary beeb tv was the best I have seen
( following some really dire ones)
and she was on again 14 00 so they seem to be running with it
Peter P will be along shortly to explain.(if you can understand him.)//
see one oclock news today - really very good summing up
but I did stir them up with the observation that antibody levels werent be all and end all.
but
There has never been a vaccine for the common cold so how can one for covid be created so quickly
easy - common cold 200 types and easily mutates
covid so far - - - mutation but very little
and some covid bits - no mutation so it makes sense to get an antibody against the non changing bits
that OK isnt it?
Incomprehensible bit - the virus docks on a well described human cell receptor and then gains entry to the cell and KKKKKIIIIIILLLLS it and so
define the protein bit of that part - - - and get a vaccine
because the antibody should - - - interfere with docking
actually they have identified a very stable sequence ( the idea is if the sequence changes then the virus wont dock) just under the binding site and one of the vaccines is against that sequence
the one oclock summary beeb tv was the best I have seen
( following some really dire ones)
and she was on again 14 00 so they seem to be running with it
in terms of it is so quick
are they cutting corners?
No the steps taken have been adequate / good
there have been surprises - the president thinking he cd win an election if he empowered it ( use of the vaccine)
the pharma unexpectedly saying no mr president
and the unexpected thing of - it should have happened at all.
are they cutting corners?
No the steps taken have been adequate / good
there have been surprises - the president thinking he cd win an election if he empowered it ( use of the vaccine)
the pharma unexpectedly saying no mr president
and the unexpected thing of - it should have happened at all.
short answer to that one
we cant really do T cell assays
this lot say they can
https:/
and then can we have £50k please which kinda gives away the reason that they say it will get up and run
and there is A LOT of this around
we do T cell assays for renal transplantation and the French dont
and - - - the results are the same - therefore .....
we cant really do T cell assays
this lot say they can
https:/
and then can we have £50k please which kinda gives away the reason that they say it will get up and run
and there is A LOT of this around
we do T cell assays for renal transplantation and the French dont
and - - - the results are the same - therefore .....
The main reason that vaccine developments is proceeding at pace is because of previous research into the structurally similar SARS and MERS virus. Research has never been from scratch and previous work has put us ahead considerably. In a broad sense, yes, there are very common features with SARS-CoV-2, SARS, MERS and even the common cold virion variants.
As to our knowledge of coronavirus, I can tell you that we know a huge amount more about the virion that we did in the early months of this years. I've worked on research of the virion in three secure research facilities in the UK on and off since March as well as continuing with my my university duties and rest assured, our knowledge of the pathogen is increasing.
The effectiveness of vaccination against covid is a difficult question to answer right now here not least because there are many differing opinions in both academia and research facilities on the subject. My opinion might not be the same as my colleagues on the matter. Nevertheless,intensive research into the way forward has never really stopped in recent months and I remain optimistic.
As to our knowledge of coronavirus, I can tell you that we know a huge amount more about the virion that we did in the early months of this years. I've worked on research of the virion in three secure research facilities in the UK on and off since March as well as continuing with my my university duties and rest assured, our knowledge of the pathogen is increasing.
The effectiveness of vaccination against covid is a difficult question to answer right now here not least because there are many differing opinions in both academia and research facilities on the subject. My opinion might not be the same as my colleagues on the matter. Nevertheless,intensive research into the way forward has never really stopped in recent months and I remain optimistic.
1 to 13 of 13
Latest Posts
ChatterBank7 mins ago
ChatterBank10 mins ago
Technology22 mins ago
Are The West In The Grip Of The Woke...
News24 mins ago
ChatterBank42 mins ago
